New in MMWR: Candida auris containment in dialysis centers, and more

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

C. auris and Dialysis

July 10, 2025

WEEKLY REPORT

Candida auris Containment Responses in Health Care Facilities that Provide Hemodialysis Services

In five facilities providing dialysis in four states, six patients were infected or colonized with C. auris and received dialysis for up to 4 months without transmission of the pathogen to other patients. Among 174 potentially exposed patient contacts, no new Candida auris patients were identified. In some instances, no additional control measures other than standard dialysis infection prevention and control practices were used.

• Erratum: Vol. 74, No. 18

• Erratum: Vol. 73, No. 41

READ THE WEEKLY REPORTS

PDF of this issue (link)

Questions about this MMWR? Contact us at mmwrq@xxxxxxx

MOST READ THIS WEEK

• Foodborne Botulism Outbreak After Consumption of Home-Canned Cactus (Nopales) — Fresno County, California, June 2024
• Mycoplasma pneumoniae Infections in Hospitalized Children — United States, 2018–2024
• Notes from the Field: Parvovirus B19 Activity — United States, January 2024–May 2025
• Notes from the Field: Increase in New Delhi Metallo-β-Lactamase–Producing Carbapenem-Resistant Enterobacterales — New York City, 2019–2024
• Suicide Rates by Industry and Occupation — National Vital Statistics System, United States, 2021

 

CONTINUING EDUCATION

New MMWR Medscape CE on U.S. Selected Practice Recommendations for Contraceptive Use, 2024

EARN FREE CE

Don’t miss out! This free CE activity expires soon: Deaths from Excessive Alcohol Use — United States, 2016–2021

In Case You Missed It

Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV — CDC Recommendations, United States, 2025

These 2025 nonoccupational postexposure prophylaxis (nPEP) guidelines update recommendations and considerations for use of HIV nPEP in the United States to include newer antiretroviral (ARV) agents, updated nPEP indication considerations, and emerging nPEP implementation strategies. The guidelines also include considerations for testing and nPEP regimens for people exposed who have received long-acting injectable ARVs in the past. Lastly, testing recommendations for people who experienced sexual assault were updated to align with the most recent CDC sexually transmitted infection treatment guidelines.

Surveillance for Violent Deaths — National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022

Of the 74,148 deaths that occurred in all 50 states and DC in 2022, the majority (60.6%) were suicides, followed by homicides (30.2%). More than half of the deaths (57%) involved firearms.

U.S. Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |